5866-97-7

Usage

Uses

Used in Organic Synthesis:
2,6-Dichloro-3-nitrobenzaldehyde is used as a reagent in the preparation of a wide range of chemical compounds, including dyes and fluorescent brighteners. Its chemical versatility makes it a valuable component in the development of new materials with specific properties.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 2,6-Dichloro-3-nitrobenzaldehyde is utilized as a precursor in the synthesis of various drugs. Its unique structure contributes to the creation of medicinal compounds with targeted therapeutic effects.
Used in Agrochemical Manufacturing:
2,6-Dichloro-3-nitrobenzaldehyde also serves as an intermediate in the manufacturing of herbicides and insecticides. Its role in these products is crucial for the development of effective crop protection agents.
Used in Cancer and Disease Research:
Due to its unique chemical properties, 2,6-Dichloro-3-nitrobenzaldehyde has been studied for its potential use in the treatment of cancer and other diseases. Its exploration in this field is driven by the search for novel therapeutic agents that can target specific biological pathways.

InChI:InChI=1/C7H3Cl2NO3/c8-5-1-2-6(10(12)13)7(9)4(5)3-11/h1-3H

Upstream product

• 83-38-5 2,6-dichlorobenzaldehyde 
• 118-69-4 2,6-dichlorotoluene 

Downstream Products

• 611-06-3 2,4-dichloronitrobenzene 
• 4659-47-6 2,3,6-trichlorobenzaldehyde 
• 860725-31-1 3-amino-2,6-dichloro-benzaldehyde 
• 89583-94-8 2,6-dichloro-3-nitro-benzaldehyde seqtrans-oxime 
• 860553-78-2 3-nitro-2,6-bis-(toluene-4-sulfonylamino)-benzaldehyde 
• 23817-57-4 C₈H₇Cl₂N₅O₂ 
• 37083-37-7 5,10,15,20-tetrakis(2,6-dichlorophenyl)porphyrin 
• 131336-19-1 meso-5-(2,6-dichloro-3-nitrophenyl)-10,15,20-tri(2,6-dichlorophenyl)porphyrin 
• 141114-44-5 2-<(2,6-dichloro-3-nitrobenzyl)amino>propionamide 
• 160647-01-8 2,6-Dichloro-3-nitrobenzyl alcohol 
• 64-18-6 formic acid 
• 17999-12-1 1-(2,3,6-trichloro-phenyl)-ethanone 
• 53065-98-8 1-(2,3,6-trichloro-phenyl)-ethanol 
• 1141888-57-4 ethyl 2-amino-5-chloro-8-nitroquinoline-2-carboxylate 

Relevant academic research and scientific papers

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

N-SUBSTUTUTED-6-OXO-1,6-DIHYDROPYRIMIDINE-2-YL DERIVATIVES AS INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula I

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

A compound of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: (I)

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: (I)

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

A pharmaceutical composition comprising the compound of Formula Ia, Formula Ib, Formula Ic, or Formula Id, or a pharmaceutically acceptable salt thereof, is set forth. (Formula Ia), (Formula Ib), (Formula Ic), (Formula Id)

N-SUBSTITUTED-4-OXO-3,4-DIHYDROPYRIDO[2,3-D]PYRIMIDIN-2-YL DERIVATIVES AS INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth Formula I.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula I.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula I

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula I

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula (I), including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: